Activities of Oreste ROSSI related to 2013/2022(INI)
Reports (1)
REPORT on the report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare- associated infections PDF (244 KB) DOC (139 KB)
Amendments (93)
Amendment 1 #
Motion for a resolution
Citation 6
Citation 6
Amendment 3 #
Motion for a resolution
Citation 6 a (new)
Citation 6 a (new)
– having regard to Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross- border healthcare,
Amendment 4 #
Motion for a resolution
Citation 6 d (new)
Citation 6 d (new)
– having regard to the report of the European Parliament on the proposal for a Council recommendation on patient safety, including the prevention and control of healthcare associated infections (COM(2008)0837 – C6-0032/2009 – 2009/0003(CNS)),
Amendment 5 #
Motion for a resolution
Citation 6 f (new)
Citation 6 f (new)
– having regard to its resolution of 12 May 2011 on antibiotic resistance,
Amendment 6 #
Motion for a resolution
Citation 6 c (new)
Citation 6 c (new)
– having regard to the Commission recommendation of 27 October 2011 on the research Joint Programming Initiative ‘The Microbial Challenge – An Emerging Threat to Human Health’ (C(2011)7660),
Amendment 7 #
Motion for a resolution
Citation 6 e (new)
Citation 6 e (new)
– having regard to its resolution of 27 October 2011 on the public health threat of antimicrobial resistance,
Amendment 8 #
Motion for a resolution
Citation 6 i (new)
Citation 6 i (new)
– having regard to its report of 15 November 2012 on ‘The Microbial Challenge – Rising threats from Antimicrobial Resistance’ (2012/2041),
Amendment 10 #
Motion for a resolution
Citation 6 g (new)
Citation 6 g (new)
– having regard to the Staff working paper of the services of the Commission on antimicrobial resistance of 18 November 2009 (SANCO/6876/2009r6),
Amendment 13 #
Motion for a resolution
Citation 6 b (new)
Citation 6 b (new)
– having regard to the Commission Communication of 15 November 2011 on an action plan against antimicrobial resistance (COM(2011)0748),
Amendment 17 #
Motion for a resolution
Citation 6 h (new)
Citation 6 h (new)
– having regard to the Joint Technical Report by the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) of 17 September 2009 on ‘The bacterial challenge: time to react – A call to narrow the gap between multidrug- resistant bacteria in the EU and the development of new antibacterial agents’,
Amendment 19 #
Motion for a resolution
Citation 6 o (new)
Citation 6 o (new)
– having regard to Special Eurobarometer 338 on Antimicrobial Resistance, published in April 2010,
Amendment 20 #
Motion for a resolution
Citation 6 j (new)
Citation 6 j (new)
– having regard to the 2008 and 2012 annual epidemiological reports by the European Centre for Disease Prevention and Control (ECDC),
Amendment 21 #
Motion for a resolution
Citation 6 k (new)
Citation 6 k (new)
– having regard to the European Centre for Disease Prevention and Control (ECDC) technical document entitled ‘Core competencies for infection control and hospital hygiene professionals in the European Union’ published on 26 March 2013,
Amendment 22 #
Motion for a resolution
Citation 6 l (new)
Citation 6 l (new)
– having regard to the communication of 15 December 2008 from the Commission to the European Parliament and the Council on patient safety, including the prevention and control of healthcare- associated infections (COM(2008) 837 final),
Amendment 23 #
Motion for a resolution
Citation 6 m (new)
Citation 6 m (new)
– having regard to the Commission’s Impact Assessment of December 2008,
Amendment 24 #
Motion for a resolution
Citation 6 n (new)
Citation 6 n (new)
– having regard to the Special Eurobarometer survey on ‘Patient Safety and Quality of Healthcare’, published in April 2010,
Amendment 25 #
Motion for a resolution
Citation 6 p (new)
Citation 6 p (new)
– having regard to the Special Eurobarometer survey on ‘Patient involvement’ published in May 2012,
Amendment 26 #
Motion for a resolution
Citation 6 q (new)
Citation 6 q (new)
– having regard to the Council Conclusions on common values and principles in European Health Systems (OJ C 146, 22.06.2006, p.1),
Amendment 27 #
Motion for a resolution
Citation 6 r (new)
Citation 6 r (new)
– having regard to the WHO report entitled ‘Core components for infection prevention and control programmes’,
Amendment 28 #
Motion for a resolution
Citation 6 s (new)
Citation 6 s (new)
– having regard to the Report of the second meeting of the Informal Network on Infection Prevention and Control in Health Care (June 2008),
Amendment 29 #
Motion for a resolution
Citation 6 t (new)
Citation 6 t (new)
- having regard to World Health Assembly Resolution WHA55.18 on ‘Quality of care: patient safety’ of 18 May 2002,
Amendment 30 #
Motion for a resolution
Citation 6 u (new)
Citation 6 u (new)
– having regard to the Commission's White Paper entitled ‘Together for Health: A Strategic Approach for the EU 2008-2013’ of 23 October 2007.
Amendment 31 #
Motion for a resolution
Citation 6 v (new)
Citation 6 v (new)
- having regard to the second programme of Community action in the field of health (2008-13) which seeks to improve citizens’ health security, and to promote measures aimed at optimising patient safety by means of high-quality, safe health care, including in the area of microbial resistance to antibiotics and nosocomial infections,
Amendment 33 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Aa. whereas high-quality healthcare is the cornerstone of any high-quality health system and whereas access to high-quality healthcare is recognised as a fundamental right by the EU, the European institutions and European citizens;
Amendment 35 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas the issue of patient safety is becoming a growing concern in health systems throughout the world, including in Europe;
Amendment 41 #
Motion for a resolution
Recital K b (new)
Recital K b (new)
Kb. whereas it is essential to uphold citizens’ confidence in the health systems of the European Union;
Amendment 46 #
Motion for a resolution
Recital H b (new)
Recital H b (new)
Hb. whereas, however, it is estimated that between 30% and 40% of adverse events in both hospital and out-of-hospital (ambulatory) care appear to be caused by systemic factors and are thus avoidable;
Amendment 48 #
Motion for a resolution
Recital F
Recital F
F. whereas, furthermore, elderly patients and patients with immunodeficiencies or chronic diseases, in particular degenerative diseases, are especially vulnerable to healthcare-related adverse events, such as: diagnostic errors; lack of follow-up on medical examinations; the prescription, dispensing or administration of an inappropriate (e.g. off-label) medicine, of an incorrect dose or of two medicines which should not be combined; the failure or poor disinfection of medical equipment; or the infection of surgical scars;
Amendment 51 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas, therefore, the European Union’s action in the field of patient safety consists in helping Member States to coordinate their efforts in this area and supporting their actions in fields where its intervention can provide an added value;
Amendment 52 #
Motion for a resolution
Recital H a (new)
Recital H a (new)
Ha. whereas international studies estimate that between 13% and 16% of hospital costs (one euro in every seven) are incurred as a result of healthcare related incidents;
Amendment 53 #
Motion for a resolution
Recital G b (new)
Recital G b (new)
Gb. whereas a lack of financial, technical and human resources is particularly associated with an increased risk of healthcare related adverse events;
Amendment 55 #
Motion for a resolution
Recital G c (new)
Recital G c (new)
Gc. whereas the economic crisis has slowed the implementation of measures adopted by the Member States in 2009, as a result of changed priorities in public health;
Amendment 56 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas HAIs are among the most common – and often the most dangerous – causes of involuntary harm to patients;
Amendment 58 #
Motion for a resolution
Recital C b (new)
Recital C b (new)
Cb. whereas HAIs, which, on average, are acquired by 5% of patients admitted to hospital, some 4.1 million patients each year, in the European Union and have a high impact in terms of morbidity, mortality (with 37 000 people dying directly of such infections in the European Union) and cost (estimated at over EUR 5.5 billion per year in Europe), constitute a major public health problem in the countries of the European Union;
Amendment 62 #
Motion for a resolution
Recital K c (new)
Recital K c (new)
Kc. whereas, since the micro-organisms responsible for HAIs are capable of colonising the human body for long periods, patients can spread them not only during their hospital stay but also afterwards, and whereas HAIs can thus affect all care premises, medium- and long-term care establishments and even the patient’s home;
Amendment 65 #
Motion for a resolution
Recital I a (new)
Recital I a (new)
Ia. whereas a HAI contracted during a hospital stay may not display symptoms until after the patient has been discharged;
Amendment 66 #
Motion for a resolution
Recital J a (new)
Recital J a (new)
Ja. whereas the average length of a hospital stay in the Member States of the European Union is falling;
Amendment 67 #
Motion for a resolution
Recital J b (new)
Recital J b (new)
Jb. whereas the percentage of patients affected by infections following home care is unknown, and whereas home care is often provided to patients with chronic or degenerative diseases who have not been admitted to hospital;
Amendment 68 #
Motion for a resolution
Recital J d (new)
Recital J d (new)
Jd. whereas patients with chronic or degenerative diseases often receive home care instead of being admitted to hospital;
Amendment 69 #
Motion for a resolution
Recital J e (new)
Recital J e (new)
Je. whereas the condition of some people with chronic or degenerative diseases often requires permanent and continuous medical assistance, very frequently necessitating, in particular, the use of medical devices (cardiac stimulators, respiratory devices, catheters, urinary catheters, etc.);
Amendment 70 #
Motion for a resolution
Recital J f (new)
Recital J f (new)
Jf. whereas the use of such medical devices requires strict application of the procedures for use, in accordance with guidelines and established good practice;
Amendment 71 #
Motion for a resolution
Recital J g (new)
Recital J g (new)
Jg. whereas the use of such medical devices carries a risk of infection;
Amendment 73 #
Motion for a resolution
Recital J c (new)
Recital J c (new)
Jc. whereas simple and cost-effective action to prevent HAIs, such as sanitation education (in particular, the promotion of hospital hygiene), already exists or is currently being tested on an experimental basis, with promising results, and whereas potential alternative, cost-effective ways of combating HAIs could usefully be explored;
Amendment 75 #
Motion for a resolution
Recital K
Recital K
K. whereas, furthermore, people’s increasing mobility within and between national healthcare systems inside the EU and their, the increasingly cross-border nature of healthcare in Europe and people’s freedom to seek medical treatment outside their countries of residence are making it easier for resistant micro-organisms to spread rapidly from one Member State to another;
Amendment 76 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. whereas the results of the Eurobarometer survey on ‘Patient Safety and Quality of Healthcare’ indicate both that European public opinion is highly aware of this issue and also that there is a marked lack of information on patient safety;
Amendment 78 #
Motion for a resolution
Recital K d (new)
Recital K d (new)
Kd. whereas HAIs are often difficult to treat, as the micro-organisms responsible for them are frequently resistant to antimicrobial agents;
Amendment 79 #
Motion for a resolution
Recital H d (new)
Recital H d (new)
Hd. whereas antibiotic resistance in Europe is continuing to increase, and for certain bacteria may be 25%, or even more, in several Member States;
Amendment 80 #
Motion for a resolution
Recital H c (new)
Recital H c (new)
Hc. whereas in the EU, Iceland and Norway alone antimicrobial resistant bacteria cause some 400 000 infections and 25 000 deaths annually, with at least EUR 1.5 billion spent on extra healthcare costs and productivity losses;
Amendment 82 #
Motion for a resolution
Recital K e (new)
Recital K e (new)
Ke. whereas the development of resistance to antimicrobial agents can be accelerated, in particular, by the inordinate and indiscriminate use of these products in human medicine, which, combined with insufficient hygiene and infection control, can compromise the effective use of an already limited number of existing antimicrobial agents;
Amendment 84 #
Motion for a resolution
Recital H e (new)
Recital H e (new)
He. whereas the latest available data indicate that antibiotic resistance markers for the bacteria involved in HAIs highlight an increasing global trend towards multi-resistance, and, in particular, an increase in the percentage of Enterobacteriaceae resistant to 3rd generation cephalosporins and of methicillin resistant S. aureus;
Amendment 85 #
Motion for a resolution
Recital H f (new)
Recital H f (new)
Hf. whereas there is a growing gap between increasing resistance to antimicrobial agents and the development of new antimicrobial agents;
Amendment 86 #
Motion for a resolution
Recital H g (new)
Recital H g (new)
Hg. whereas the development of resistance to antimicrobial agents is a natural and unavoidable consequence of their use, but whereas it can be limited through their prudent and rational use;
Amendment 87 #
Motion for a resolution
Recital H h (new)
Recital H h (new)
Hh. whereas the development of resistance to antimicrobial agents can be accelerated, in particular, by the inordinate and indiscriminate use of these products in human medicine, which, combined with insufficient hygiene and infection control, can compromise the effective use of an already limited number of existing antimicrobial agents;
Amendment 88 #
Motion for a resolution
Recital H i (new)
Recital H i (new)
Hi. whereas, in view of the lack of development of new antibiotics/antimicrobial agents, it is vital for current antimicrobial agents to be used effectively for as long as possible;
Amendment 91 #
Motion for a resolution
Recital K f (new)
Recital K f (new)
Kf. whereas, according to the results of the Eurobarometer survey on ‘Antimicrobial Resistance’, 53% of people questioned still believed in 2010 that antibiotics were effective against viruses, 20% took antibiotics to tackle influenza and 14% to combat colds, and 5% of people took antibiotics obtained without a medical check-up;
Amendment 92 #
Motion for a resolution
Recital K g (new)
Recital K g (new)
Kg. whereas consumption of antibiotics is higher among people who are objectively least well informed and whereas better objective knowledge of antibiotics is associated with more responsible behaviour in terms of their use;
Amendment 93 #
Motion for a resolution
Recital K h (new)
Recital K h (new)
Kh. whereas certain Member States do not have a solid regulatory and legal framework to support and make compulsory the rational use of medicines, and whereas there are strong disparities in Europe in terms of consumption of antibiotics, in the context of both community and hospital care;
Amendment 94 #
Motion for a resolution
Recital K i (new)
Recital K i (new)
Ki. whereas there is a need to educate and raise awareness among those involved in antimicrobial use, including policy- makers, health professionals and the general public, in order to encourage necessary changes in the behaviour of prescribers, dispensers and citizens;
Amendment 95 #
Motion for a resolution
Recital K j (new)
Recital K j (new)
Kj. whereas, since the adoption in 2009 of Council Recommendation 2009/C 151/01, substantial effort has been invested in adopting and implementing strategies (national and regional) for the prevention and control of HAIs in the Member States, particularly through the adoption of guidelines on the prevention and control of HAIs and by setting up active HAI surveillance systems (or strengthening those that already exist);
Amendment 96 #
Motion for a resolution
Recital K ja (new)
Recital K ja (new)
Kja. whereas, on the other hand, some of the action recommended by the Council in its Recommendation 2009/C 151/01 on how to improve patient safety in the Member States has thus far been implemented by only a limited number of Member States, and whereas there is room for improvement – in both hospital and non-hospital care – particularly in respect of patient empowerment and the overall training of health professionals and carers, as well as in the implementation of European classifications on patient safety and the development of European guidelines on patient safety standards;
Amendment 97 #
Motion for a resolution
Recital K k (new)
Recital K k (new)
Kk. whereas, since the adoption in 2009 of Council Recommendation 2009/C 151/01, substantial effort has been invested in improving patient safety in the Member States, particularly by embedding patient safety as a priority in public health policies in all Member States, by designating a competent authority responsible for patient safety (in 19 Member States) and encouraging training on patient safety in healthcare establishments (in 23 Member States);
Amendment 98 #
Motion for a resolution
Recital K l (new)
Recital K l (new)
Amendment 99 #
Motion for a resolution
Recital K m (new)
Recital K m (new)
Km. whereas, on the other hand, some of the action recommended by the Council in its Recommendation 2009/C 151/01 on how to improve patient safety in the Member States has thus far been implemented by only a limited number of Member States, and whereas there is room for improvement – in both hospital and non-hospital care – particularly in respect of patient empowerment and the overall training of health professionals and carers, as well as in the implementation of European classifications on patient safety and the development of European guidelines on patient safety standards;
Amendment 100 #
Motion for a resolution
Recital K n (new)
Recital K n (new)
Kn. whereas, on the other hand, some of the specific measures the Council recommended for preventing and combating HAIs in the Member States have been implemented in only a limited number of Member States, and whereas progress is still possible, particularly in respect of provision of information to patients by healthcare establishments and support for research into the prevention and control of HAIs;
Amendment 101 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Welcomes the measures put in place by Member States with the principal aim of improving general patient safety and reducing the incidence of HAIs; , and in particular by; – all Member States drawing up patient safety policies, and the fact that many Member States have made these policies a priority of their healthcare policy; – the designation of a competent authority responsible for patient safety in most Member States; – the gradual establishment of mechanisms for reporting adverse events and learning lessons from such failings; – the widespread introduction of patient safety training campaigns in healthcare establishments; – the implementation, in France, Slovakia and the Netherlands, of cross-border patient-safety strategies (in addition to the national strategy); – collaboration between countries and between regions with a view to carrying out the action recommended by the Council and implemented by 21 Member States (plus Norway), frequently in the context of projects cofinanced by the European Union;
Amendment 104 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the steps taken by the Commission to improve general patient safety by promoting mutual learning between Member States and putting forward common definitions and terminology for patient safety; and in particular: – the Commission fostering the exchange of information on initiatives concerned with patient safety and quality of care in the context of the Working Group on Patient Safety and Quality of Care; – the Commission’s cofinancing of the OECD-led project on healthcare quality indicators, which has made it possible to collect comparable indicators of patient safety in 11 countries; – the European Union’s cofinancing, under the seventh framework programme for research, of six research projects on general patient safety; – the adoption of Directive 2011/24/EU of the European Parliament and of the Council on the application of patients’ rights in cross-border healthcare, which seeks not only to clarify the rights of patients when accessing care in another EU Member State, but also to ensure that such care is safe and of good quality;
Amendment 110 #
Motion for a resolution
Paragraph 4 – indent 1 a (new)
Paragraph 4 – indent 1 a (new)
- have integrated patient safety into the education and training of health professionals;
Amendment 113 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Welcomes the Commission’s action in the area of preventing and combating HAIs, which is closely linked to its action in the area of resistance to antimicrobial agents, in particular the financing provided by the Commission for research projects on HAIs and antimicrobial resistance, especially those projects having a European dimension, such as IPSE (Improving Patient Safety in Europe), IMPLEMENT (Implementing Strategic Bundles for Infection Prevention and Management) and PROHIBIT (Prevention of Hospital Infections by Intervention and Training), which seeks to analyse existing practical guidelines on prevention of HAIs in European hospitals and test a strategy for preventing bloodstream infections linked to central venous catheters (infections which are particularly worrying in that they are associated with significant morbidity and a high level of directly related mortality);
Amendment 115 #
Motion for a resolution
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Welcomes the coordination and monitoring work of the European Centre for Disease Prevention and Control (ECDC), in particular: – its activities in coordinating the European network for surveillance of HAIs, particularly surgical site infections, HAIs acquired in intensive care units and antimicrobial use in long-term care facilities (HALT-2), as well as its support for the European project to support capacity building for surveillance of Clostridium difficile infections (ECDIS- Net); – the coordination of a European study on HAI prevalence and antimicrobial use in acute care hospitals; – the ECDC’s development of guidance for the prevention and control of Clostridium difficile infections; – the publication of recommendations to prevent the spread of carbapenemase- producing Enterobacteriaceae; - the ECDC’s support for the development of guidelines and indicators (on structure and method) for preventing HAIs.
Amendment 116 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Urges the Member States to continue their efforts to improve patient safety by taking, if they have not already done so, newadditional measures in order to fall fully into line with the Council’s recommendations;
Amendment 119 #
Motion for a resolution
Paragraph 10 – indent 2
Paragraph 10 – indent 2
– education and training measures for healthcare workers in the area of patient safety, to include the introduction of compulsory patient safety training modules (covering various areas including medical devices and good use of medicines) in one or more types of study or training for healthcare professionals and carers;
Amendment 128 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Urges the Member States to introduce, or strengthen iWhile acknowledging that the EU may not interfere with the Member States’ powers in the field of they already exist, arrangements for reporting adverse events which make it possible to identify those responsible in the event of a breakdown in the chain of care and learn lessons from such breakdownalth, urges Member States not to cut the budgets allocated to patient safety, a key issue for European healthcare systems at a time of global spending reviews;
Amendment 129 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Urges the Member States to introduce, or strengthen if they already exist, arrangements for reporting adverse events which make it possible to identify those responsible in the event of a breakdown in the chain of care and learn lessons from such breakdowns;
Amendment 134 #
Motion for a resolution
Paragraph 11 b (new)
Paragraph 11 b (new)
11b. Urges the Commission and the Member States to make the public more aware of initiatives in the area of patient safety and empower patients in this area;
Amendment 144 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15a. Calls on the Member States to apply, wherever possible, hospital patient safety strategies and programmes in non- hospital care environments (in long- and medium-stay facilities, but also in the home);
Amendment 158 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. CWhile acknowledging that the EU may not interfere with the Member States’ powers in the field of health, calls on the Member States to make sufficient human, financial and technological resources available to ensure that care provided in the home or in hospital is of the highest possible quality, and urges them, in particular, not to cut the budgets allocated to patient safety, a key issue for European healthcare systems at a time of global spending reviews;
Amendment 163 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Calls on the Member States and the Commission to foster, including by means of awareness-raising campaigns, good practices in all areas, in particular all those linked to hygiene (hand hygiene, sterilisation of instruments, etc.) both in and outside hospital (in particular vis-à- vis patients and their families)take action (involving both public awareness-raising campaigns and measures targeted at healthcare professionals) at national, local and European level to promote rational use of antibiotics, both in community care and in hospitals;
Amendment 173 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Member States to use the most advanced technological means available to guarantee optimum patient safety, and, in particular, to introduce across the board electronic health passports containing all relevant information about the patient, including his or her antecedents; points out that the confidentiality of the personal data provided in connection with the issue of such passports must be guaranteed;
Amendment 178 #
Motion for a resolution
Paragraph 22 – indent -1a (new)
Paragraph 22 – indent -1a (new)
– the state of health of patients (particularly elderly persons and persons with reduced mobility) returning home after a period of hospitalisation must be assessed thoroughly when they leave hospital, with a view, in particular, to evaluating and countering the risk of falls;
Amendment 179 #
Motion for a resolution
Paragraph 22 – indent 2
Paragraph 22 – indent 2
– patients and their carers must be properly informed, in particular about hand hygiene matters,and the need to disinfect reusable medical instruments and devices, as well as the need to comply with procedures and prescriptions;
Amendment 182 #
Motion for a resolution
Paragraph 22 – indent 2 a (new)
Paragraph 22 – indent 2 a (new)
– the taking of basic precautions should be encouraged, in particular as regards the storage and use of medicines, and patients should, in particular, be made aware of the risks involved in using medicines that have no marketing authorisation;
Amendment 183 #
Motion for a resolution
Paragraph 22 – indent 2 b (new)
Paragraph 22 – indent 2 b (new)
– the use of throwaway medical equipment must be encouraged as far as possible;
Amendment 190 #
Motion for a resolution
Paragraph 24 – subparagraph 1 (new)
Paragraph 24 – subparagraph 1 (new)
Calls on the Member States to do what they can to ensure that patients trust their health systems and, in particular, to involve patients closely in patient safety;
Amendment 195 #
Motion for a resolution
Paragraph 25 – subparagraph 1 (new)
Paragraph 25 – subparagraph 1 (new)
Calls on the Member States to conduct specific information and training campaigns to raise awareness among patients and healthcare professionals of the issue of antimicrobial resistance;
Amendment 203 #
Motion for a resolution
Paragraph 27
Paragraph 27
27. Calls for theWhile acknowledging that the EU may not interfere with the Member States’ powers in the field of health, calls for the Member States to work together to introduction ofe compensation systems (in particular if adverse events in healthcare occur) which are harmonised at EU level;
Amendment 204 #
Motion for a resolution
Paragraph 27 – subparagraph 1 (new)
Paragraph 27 – subparagraph 1 (new)
Calls, in particular, on the Member States to set up a mediation service to improve dialogue between healthcare system users and healthcare professionals and to analyse and respond to all requests for information and all complaints concerning healthcare system quality and healthcare safety;
Amendment 205 #
Motion for a resolution
Paragraph 27 a (new)
Paragraph 27 a (new)
27a. Urges the Commission to continue to maintain contacts with patients’ associations, in particular the European Patients’ Forum;
Amendment 211 #
Motion for a resolution
Paragraph 28 – subparagraph 1 (new)
Paragraph 28 – subparagraph 1 (new)
Urges the Member States to introduce checklists, with a view to making surgical operations safer;
Amendment 217 #
Motion for a resolution
Paragraph 30 a (new)
Paragraph 30 a (new)
30a. Recommends that a list of HAIs which should be screened for in all hospitals and healthcare establishments in the EU be drawn up in cooperation with the EMA and the ECDC;
Amendment 223 #
Motion for a resolution
Paragraph 33
Paragraph 33
33. Calls on the Member States to share, where they exist, good practice benchmarks in the area of generalfor international guidelines drawn up by the WHO on patient safety, and, in particular, to share, where they exist, good practice benchmarks in the area of the on preventiong and control of HAIs and the transmission of multi- resistant bacteriambating HAIs to be implemented within the EU;
Amendment 224 #
Motion for a resolution
Paragraph 33 a (new)
Paragraph 33 a (new)
33a. Calls on the Member States to share, where they exist, good practice benchmarks in the area of HAI prevention and control and the transmission of multi-resistant bacteria (e.g. measures to prevent the spread of legionella bacteria in hospital hot-water systems);
Amendment 234 #
Motion for a resolution
Paragraph 35 a (new)
Paragraph 35 a (new)
35a. Urges the Member States to give a further boost to nosocomial infection surveillance programmes by encouraging hospitals to play a full and active part in the European nosocomial infection surveillance network;
Amendment 237 #
Motion for a resolution
Paragraph 35 b (new)
Paragraph 35 b (new)
35b. Believes that, under the eighth framework programme for research, which is to commence in 2014, the EU should cofinance research into general patient safety, HAIs and resistance to antimicrobial agents;